CardioBrief: What Will Be The Impact Of ABSORB II?

ACC Conference Reporter

TCT 2016 | Washington, DC — When it was approved earlier this year in July the Absorb (Abbott) bioresorbable stent provoked a fair amount of discussion about the "slippery slope of noninferiority." Read More >>>

Keywords: Transcatheter Cardiovascular Therapeutics


< Back to Listings